Cocapping of CD19, CD20, CD5, and CD31 with CD38
Cap/cocap . | Total cells, no. . | Caps, % . | Cocaps, % . |
|---|---|---|---|
| CD38/CD19 | 112 | 92 | 56 |
| CD38/CD20 | 97 | 81 | 38 |
| CD38/CD5 | 121 | 94 | 34 |
| CD38/CD31 | 106 | 83 | 22 |
Cap/cocap . | Total cells, no. . | Caps, % . | Cocaps, % . |
|---|---|---|---|
| CD38/CD19 | 112 | 92 | 56 |
| CD38/CD20 | 97 | 81 | 38 |
| CD38/CD5 | 121 | 94 | 34 |
| CD38/CD31 | 106 | 83 | 22 |
Table shows cumulative data from 6 different experiments described in Figure 4. The number of caps and cocaps are presented as a percentage of the cells analyzed. Cells exhibiting partial redistribution of the surface molecule detected by the primary capping antibody were excluded from the analysis.